Acute lung injury (ALI) is considered to be an inflammatory syndrome of the airway system that is initiated by failure of the respiratory system. In this study, we evaluated the possible benefits of some novel thiazole derivatives against ALI. These derivatives were synthesised and evaluated for the inhibition of MMP-8 and MMP-2. Most of the tested compounds had better inhibitory activity for MMP-8 than for MMP-2, with compound 26 being the most potent analogue among the tested series. Thus, compound 26 was further investigated to determine its beneficial effects in an ALI model of rats with sepsis. In vivo results suggested that compound 26 significantly reduced the protein concentration together with a decline in enhanced leukocytes compared with those in ALI induced by cecal ligation and puncture. The effect of compound 26 on myeloperoxidase activity was also quantified, which was found to be significantly reduced at the maximum tested dose of 20 mg kg
Introduction
Sepsis is classied as a general inammatory response induced by infection during burns, trauma, or hypoxia, and aer surgery, which oen leads to multi-organ dysfunction and death. [1] [2] [3] Despite recent advances in the modalities of clinical approaches for the management of sepsis, there are still difficulties in managing patients with this condition. 4, 5 Various studies and statistical analyses have revealed that, each year, more than 18 million people suffer from sepsis. 6 The number of septic infections is rising at an annual rate of 1.5-8.0%, with mortality ranging from 25% to 50%. 7, 8 Among cases of sepsis, the lung is classied as the most affected organ and lung damage is largely responsible for the resulting mortality. 9 Lung function is greatly hindered by acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS). 10 It is considered to be an inammatory syndrome of the airway system initiated by failure of the respiratory system, resulting from direct/indirect damage to the vasculature of the lung.
11,12
This damage leads to increased permeability of leukocytes, together with an enhanced inammatory response and oxidative stress in the lungs. 13, 14 Novel agents rather than just ventilation are urgently needed to treat sepsis-induced ALI/ARDS and attenuate the associated pathological changes. Because of the involvement of septic shock in multi-organ failure, 15 various studies have focused on the management and attenuation of the inammatory response, which is thought to be critically involved in the induction of sepsis. 16, 17 It has also been conrmed that metalloproteinases (MMPs) play a key role in the regulation of the septic inammatory response. 18, 19 Apart from degradation of the extracellular matrix (ECM), MMPs are thought to be responsible for modifying the diverse group of non-ECM proteins, which ultimately interfere with the inam-matory process. 20 Various rodent studies of sepsis have conrmed that the inhibition of MMPs has a signicant inu-ence on the expression of inammatory markers, together with improved levels of mortality in the experimental animals.
The non-selective inhibition of MMPs oen leads to an irrelevant pharmacological response because of its involvement in many regulatory processes. 22 Thus, the selective targeting of specic MMPs can overcome the unwanted side effects. 23 Among the family of MMPs, MMP-8, a neutrophil-derived collagenase, is believed to be involved in damage to type I collagen. 24 It has also been shown to be present in a diverse range of cell types, such as macrophages, broblasts, epithelial cells, and other immune cells, and can regulate proinammatory chemokines. 25 Among the heterocyclic compounds, the thiazoles and their derivatives are important bioactive molecules due to their excellent pharmacological activity. 26 The signicance of thiazoles is emphasised by the fact that various drugs originate from them, such as antineoplastic agents (tiazofurin and dasatinib), 27 an anti-HIV drug (ritonavir), 28 an antifungal agent (ravuconazole), 29 an antiparasitic agent (nitazoxanide), 30 and an antiulcer agent (nizatidine).
31
Thiazoles have also been reported to exhibit anti-inammatory activity 32 and are included among clinically relevant drugs, such as fanetizole, meloxicam, and fentiazac.
33Ö zdemir et al. reported the MMP inhibitory activity of some thiazoles. 34 Thus, in this study, we attempted to determine the effect of some novel thiazole derivatives against MMP-8 and subsequently investigated their benecial effects in an ALI model of rats with sepsis.
Result

Chemistry
The title compounds were synthesised with an excellent yield via the facile synthetic route shown in Schemes 1 and 2. In the rst stage, various substituted phenyl thiazoles 3(a-e) were obtained by the reaction of acetophenone 1(a-e) with thiourea (2) using ammonia solution as a base. In the second stage, 2-chloro-N-[4-(p-substituted phenyl)-thiazol-2-yl]-acetamides 4(ae) were obtained by the reaction of substituted phenyl thiazole 3(a-e) with chloroacetyl chloride, as shown in Scheme 1. Finally, the title compounds 6-30 were obtained by the reaction of 2-chloro-N-[4-(p-substituted phenyl)-thiazol-2-yl]-acetamides 4(ae) with various phenyl piperazine derivatives 5(i-v) in ethanol, as shown in Scheme 2.
The structures of all synthesised compounds were ascertained by mass spectrometry, 1 H-NMR, 12 C-NMR, FT-IR, and elemental analysis. The FT-IR spectra of all synthesised derivatives 6-30 were characterised by the appearance of strong bands at 3398-3387 cm À1 , which conrmed the presence of a secondary amine group. There was another strong band at 3143-3142 cm À1 , which was attributed to stretching vibrations of the C-H group of the aromatic ring. Another strong band at 1198-1187 cm À1 conrmed the presence of an aromatic F group. The thiazole C-H group appeared at 2859-2848 cm À1 .
Another strong band at 1712-1723 cm À1 conrmed the presence of the CO group. The aromatic chloro group appeared at 798-786 cm À1 . The strong band at 662-647 cm À1 was attributed to stretching vibrations of the C-S group of the thiazole ring. The 1 H NMR spectra of the synthesised derivatives 6-30 revealed a doublet corresponding to the aromatic ring at 8.15-6.61 ppm. Furthermore, the resonance at 7.58-7.51 ppm conrmed the presence of a phenyl thiazole proton as a singlet peak. The side chain methylene proton appeared at 3.19-3.14 ppm as a single peak. The phenyl thiazole side chain NH proton appeared at 9.16-9.13 as a singlet peak. Furthermore, the resonance at 3.42-2.46 ppm conrmed the presence of a methylene proton, with a doublet peak of the piperazine ring. Finally, the structure of all of the synthesised derivatives 6-30 was conrmed by mass spectrometry and elemental analysis. Table 1 presents the MMP-2 and MMP-8 inhibitory activities of the designed analogues in the form of comparative inhibitory proles determined via residual enzyme activity, by means of continuous uorometric assays in the presence of the uores-cent substrate QF 24. The results suggest that the majority of molecules had a considerable inhibitory prole, with some exceptions where molecules showed less or no activity. In particular, molecules developed in step 1 displayed no inhibitory activity, whereas the introduction of an extended substituted side chain resulted in an improvement in activity, with the exception of compounds 6-13. The introduction of chloro and uoro groups resulted in compounds being considerably more active against both MMP-2 and MMP-9. Compounds containing electron-donating substituents (17 and 18) showed mild to moderate activity, with no inhibition in the case of compound 16. The presence of an electron withdrawing group in the R 2 position resulted in enhanced activity. The next series of compounds (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) showed excellent inhibitory activity compared to other analogues, which could be easily understood by the presence of an electron withdrawing group. The comparison of inhibitory activity indicated that molecules containing an electron withdrawing group at both sites exhibited more activity than non-halogen congeners. From these results, it was suggested that uoro groups had a more prominent inuence on the inhibitory prole, with less potency in the case of chloro-containing compounds. These results suggested that most of the compounds had better inhibitory activity for MMP-8 than for MMP-2, with compound 26 being the most potent analogue among the tested series.
In vivo pharmacological activity
Various studies have conrmed the role of MMP-8 in ALI, against which our designed compounds showed excellent inhibitory activity. Aer noting the exceptionally potent MMP-8 inhibitory activity of compound 26, we then explored the effects of this compound on the in vivo sepsis-induced lung injury of rats. As shown in Fig. 1A , it was found that compound 26 resulted in improvements following the histopathological examination of the lung tissues of experimental animals exposed to different treatments aer staining with H&E. The sham-treated group showed no abnormal architecture, whereas the cecal ligation and puncture (CLP) group had an abnormal micro-structure, with disruption to the vasculature system, increased permeability of inammatory cells into the alveolar sac, and damage to the alveolar structure. These changes were signicantly reversed to normal in the treatment group receiving compound 26 at the maximum dose of 20 mg kg À1 .
The weight ratio of wet against dry lungs was estimated to conrm the effect of compound 26 on pulmonary oedema, the results of which are presented in Fig. 2B . It was observed that the CLP-treated rats showed a signicant increase in the lung wet/dry weight ratio compared with the sham group. However, the ratio was signicantly improved only in the group receiving compound 26. The effect of compound 26 was further assayed with regard to the intensity of the inammatory process. The aim of the next phase of the study was to determine the total protein content and level of leukocytes inltrated into the BALF aer 24 h in the CLP group ( Fig. 1C-E) . The CLP-treated rats showed increased levels of total protein and leukocytes (mononuclear and polymorphonuclear) in the BALF compared with the sham-treated group. The administration of compound 26 resulted in signicant inhibition of the total protein concentration together with a decline in enhanced leukocytes (mononuclear and polymorphonuclear) compared with the CLP-treated group. In addition, the effect of compound 26 regarding MPO activity was also quantied, which is considered to be an important biomarker for the activation of neutrophils and their inltration. The results of this study are presented in Fig. 1F . It was found that the CLP group had an enhanced level of MPO activity, which was found to be signicantly reduced by the administration of compound 26 at the maximum dose of 20 mg kg À1 .
Oxidative stress is a major determinant of ALI, which has been reported to be associated with an inammatory response. This releases the reactive oxygen free radicals and is deemed to be toxic for cellular systems. Under normal circumstances, the cellular system counteracts these free radicals by maintaining an optimal balance through the endogenous antioxidant system. The antioxidant defence system comprises MDA (a biomarker for oxidative stress-mediated lipid peroxidation), SOD (a superoxide scavenger), and GSH (a nonenzymatic antioxidant system). Thus, the effect of compound 26 on these biomarkers was investigated to determine its effect on the antioxidant defence system. As shown in Fig. 2 , the lungs of rats in the CLP group had an enhanced level of MDA compared with the level in the control group. Moreover, the levels of SOD and GSH were found to be reduced in the CLP-treated lungs. The administration of compound 26 resulted in signicant attenuation of these biomarkers; that is, the MDA level was found to be reduced, while the levels of SOD and GSH were increased. Thus, it was suggested that compound 26 exerts a protective effect against ALI via modulation of the antioxidant status. Inammation plays a critical role in the progression of septic ALI, particularly when it occurs in the airways. It was found that the levels of TNF-a and IL-b were elevated in the serum of septic patients. Moreover, agents reducing the levels of these inam-matory markers have a signicant effect on overall survival in animal models. Thus, the anti-inammatory effect of compound 26 was assessed in terms of both systemic and pulmonary local inammatory responses, namely, TNF-a, IL-b, and IL-6. The results presented in Fig. 3 suggest that compound 26 caused signicant reductions of the levels of TNF-a, IL-b, and IL-6 and could protect the lung through modulation of systemic inammatory mediators in septic rats.
The levels of proinammatory enzymes, that is, COX-2 and PGE2, are known to be elevated in ALI and other inammatory diseases. The next stage of the study thus aimed at determining the effect of compound 26 on the expression of COX-2 and PGE2. As shown in Fig. 4 , compound 26 caused signicant dosedependent inhibition of both COX-2 and PGE2 compared with their levels in the CLP-treated group. Transcription of the genes encoding many inammatory proteins is mediated via NF-kB; thus, its inhibition offers a selective advantage in sepsis therapy. Under normal conditions, NF-kB is stored in the cytoplasm by IkB proteins. In the canonical pathway, IkB proteins are phosphorylated and degraded by stimulus, resulting in the rapid translocation of 
Experimental
Chemicals
The starting materials and chemicals used in the processes of synthesis were obtained from Sigma Aldrich (St. Louis, MO, USA). Avance 400 and Avance 100 spectrometers (Billerica, MA, USA) were used for the determination of 1 H NMR and 13 C NMR spectral data, respectively, in ppm for chemical shis and hertz (Hz) for the coupling constant. The mass spectrum was obtained using a liquid chromatography/mass spectrometry (LC/ MS) system (Waters ZQ; Waters, Milford, MA, USA) and an elemental analysis was conducted for C, H, and O using a Vario elemental analyser (Elementar, Langenselbold, Germany).
General procedure for synthesis of 4-((4-substituted phenyl) thiazole-2-yl)amine (3a-e)
A mixture of substituted acetophenone 1(a-e) (110 mmol) and thiourea (2) (220 mmol) in 100 mL of ethanol and then bromine (110 mmol) was added in small fractions (0.5 mL) over 3 h, with continuous stirring, and then heated on a steam bath for 8 h. A sufficient quantity of water was then added and the solution was heated until all of the solid had dissolved. The solution was ltered while hot. The ltrate was then cooled and concentrated ammonia solution was added until precipitation ceased. The solution was recrystallised with a pyridine-water (1 : 1) mixture to achieve a pure product 3(a-e). 
General procedure for synthesis of 2-chloro-N-[4-(psubstituted phenyl)-thiazol-2-yl]-acetamides 4(a-e)
Different substituted phenyl-thiazole derivatives 3(a-e) (110 mmol) were dissolved in 20 mL of pyridine, with the dropwise addition of chloroacetyl chloride (112 mmol) to the solution for 30 min with continuous stirring. The mixture was then heated on a water bath for 6 h. The mixture was cooled to room temperature and then poured onto ice. The solid was separated out and washed with distilled water, dried, and recrystallised from ethanol to give 4(a-e). 2-Chloro-N-(4-phenylthiazol-2-yl)acetamide (4a The CLP-induced sepsis model was established aer fasting for 6 h before surgery, under anaesthesia. Aer sterilisation, a 1.5 cm ventral midline abdominal incision was made and the cecum was then gently isolated and ligated with a 3-0 silk suture, punctured with an 18-gauge needle at three locations, and then repositioned. The abdomen was then closed. Rats in the sham group underwent the same surgery, but the cecum was manipulated without being ligated or perforated. Saline (2 mL/100 g body weight) was given subcutaneously to the rats immediately aer the operation for resuscitation. For the compound 26 treatment groups, rats received 10 or 20 mg kg À1 intraperitoneally 30 min before the surgery. Rats in the sham and CLP groups received only the vehicle.
Experimental setup Setup 1. At 24 h, 24 rats were randomly selected, categorised into four groups, and used for the assessment of the lung wet/ dry weight ratio.
Setup-2. At 24 h, 24 rats were randomly selected, categorised into four groups, and used for histological and molecular biological examinations. The rats in each group were anaesthetised and underwent bronchoalveolar lavage in the le lung with 1.5 mL of saline. Aer the bronchoalveolar lavage uid (BALF) and blood had been collected, the rats were killed, followed by right lung tissue collection.
Histology
The lung tissues were xed with 4% paraformaldehyde and dehydrated with a graded concentration of alcohols. Tissues were xed in paraffin and sliced into 5 mm sections. The sections were stained with haematoxylin and eosin (H&E) for 3 min and observed under a light microscope.
Measurement of the lung wet/dry weight ratio
The rat lungs were weighed immediately aer being harvested and then dried at 80 C for 72 h to achieve constant weight. The wet lung/dry lung ratio was calculated.
Analysis of total protein concentration and cell count of the BALF
The BALF was centrifuged at 1500 rpm for 10 min at 4 C. The supernatant was collected for total protein analysis using a bicinchoninic acid (BCA) protein assay kit (Beyotime Institute of Biotechnology, Haimen, China), in accordance with the manufacturer's instructions. The cell pellets were resuspended and stained with Wright-Giemsa solution for leukocyte counting using a haemocytometer. The cells were classied as mononuclear and polymorphonuclear based on their normal morphology.
Biochemical determination in lung tissues
For the measurement of oxidative states in lung tissues, the activities of myeloperoxidase (MPO) and superoxide dismutase (SOD) and the levels of malondialdehyde (MDA) and glutathione (GSH) in lung homogenates were measured using corresponding commercial kits (Jiancheng Bioengineering Institute, Nanjing, China). For the measurement of inamma-tory responses in lung tissues, levels of prostaglandin E2 (PGE2) were measured using a PGE2 Assay Kit (Wanleibio, Shenyang, China). All measurements were performed in accordance with the manufacturer's protocol.
Serum cytokines analysis
The whole blood was centrifuged at 1500 rpm for 10 min at 4 C and the serum was collected. Levels of tumour necrosis factor (TNF)-a, interleukin (IL)-1b, and IL-6 in serum were determined by enzyme-linked immunosorbent assays using commercial kits specic for rats, in accordance with the manufacturer's instructions (USCN Life Science Inc., Wuhan, China). The concentrations are expressed in picograms per milligram protein.
Immunohistochemistry
Aer being dewaxed and hydrated, sections of lung tissue were blocked with phosphate-buffered saline (PBS) containing 10% bovine serum albumin at room temperature and incubated overnight at 4 C with cyclooxygenase (COX)-2 (1 : 500, BA0738;
Wanleibio, Shanghai, China) primary antibody. Aer being incubated in biotinylated goat anti-rabbit secondary antibodies (1 : 200; Beyotime Institute of Biotechnology) for 30 min, sections were then incubated with horseradish peroxidase (HRP)-labelled streptavidin (Beyotime) for 30 min at 37 C. Each step was followed by three rinses in PBS. The peroxidase was visualized by reaction with diaminobenzidine tetrahydrochloride. Sections were counterstained with haematoxylin and analysed under an optical microscope.
Protein extraction and western blotting analysis
Lung tissues were homogenised in NP-40 lysis buffer (Beyotime) containing 1% Triton X-100 (Sinopharm Chemical Reagent Beijing Co., Ltd., Beijing, China) with 1 mM phenylmethanesulphonyl uoride (Beyotime Institute of Biotechnology) and centrifuged at 12 000g for 10 min. The supernatants were collected as total protein. Nuclear and cytosolic proteins were extracted using a nuclear and cytoplasmic protein extraction kit (Beyotime Institute of Biotechnology) following the manufacturer's protocol. A commercial bicinchoninic acid protein assay kit (Beyotime Institute of Biotechnology) was used for the determination of protein concentration. For western blot analysis, protein was subjected to 13% (w/v) sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred onto polyvinylidene diuoride (PVDF) membranes (Millipore, Billerica, MA, USA). Aer being blocked with skimmed milk in 1Â PBS in 0.05% Tween-20 for 1 h, the membrane was incubated overnight with diluted anti-COX-2 (1 : 1000, BA0738; Boster, Wuhan, China), inhibitors of NF-kBa (IkBa) (1 : 1000, bs-1287R; Bioss, Beijing, China), p65 antibodies (1 : 1000, BA0610; Boster), p-p65 ser536 antibodies (1 : 1000, bs-0982R; Bioss), Bcl-2 antibodies, and Bax antibodies in blocking buffer. The blot was washed with 1Â PBS in 0.05% Tween-20 thrice and incubated with HRP-conjugated goat anti-rabbit IgG (1 : 5000; Beyotime Institute of Biotechnology) for 1 h at room temperature. b-Actin and lamin A were used as loading controls. The blots were analysed using ImageJ soware (National Institutes of Health, Bethesda, MD, USA). The nal data were obtained by normalization with a loading control and values of the sham group.
Compound 26 treatment of A549 cells (Fig. 7) A549, a human lung epithelial cell line, was obtained from the Bioresource Collection and Research Center in Taiwan. Cells were cultured in F-12 nutrient mixture medium (Life Technologies, Carlsbad, CA, USA), which contained 10% foetal bovine serum (Biological Industries, Haemek, Israel), penicillin (100 units per mL), and streptomycin (100 mg mL À1 ). Compound 26 was dissolved in DMSO to obtain stock solutions of 10 mg mL À1 . In all cell experiments, the DMSO concentration in the culture medium was #0.1%. A549 cells were pretreated with compound 26 (1-10 mg mL À1 ) for 1 h and then stimulated with 1 mg mL À1 LPS for 24 h. The supernatants were collected and assayed with ELISA kits for the specic detection of selected chemokines or cytokines. Moreover, A549 cell viability was tested with MTT reagent. Results were assayed at 570 nm on a microplate reader (Multiskan FC; Thermo Fisher Scientic, Waltham, MA, USA).
Cell adhesion assay
A549 cells were treated with two doses of compound 26 (10 and 20 mg kg À1 ) and stimulated with LPS for 24 h, as previously described (Liou et al., 2016). A calcein-AM solution (Sigma) was then used to stain acute monocytic leukaemia cells (THP-1 cells). THP-1 cells were co-cultured with the A549 cells to observe THP-1 adhesion. Adherent cells were detected (green uorescence) with uorescence microscopy (Olympus, Tokyo, Japan).
Conclusion
We identied a novel series of thiazoles, which exert a potential protective effect against ALI via the inhibition/modulation of numerous pathways. This study provides fresh insight that should aid the development of novel therapeutics against sepsis-induced ALI; however, a more diverse range of studies are needed to validate the claims of this study.
Conflict of interest
Authors declare no conict of interest.
